Double primary recurrent human epidermal growth factor receptor 2-positive breast cancer and esophageal cancer that responded well to chemotherapy
We report a case of double primary recurrent HER2-positive breast cancer and esophageal cancer that responded well to radiotherapy and chemotherapy.
Source: International Cancer Conference Journal - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cardiovascular & Thoracic Surgery | Chemotherapy | Conferences | CT Scan | Docetaxel | Esophagus Cancer | HER2 | Herceptin | Mastectomy | PET Scan | Taxotere